Kom stor avtale nå ser det ut som, har ikke rukket å lese

28.04.2025 15:25:03
UnoMeter[T] Safeti[T] Plus is now listed with National Health Service (NHS) in England and Observe Medical has received first order from Portugal. KYC completed for largest industrial partner.
Oslo, April 28, 2025 - Observe Medical ("the Company" or "Observe Medical") is happy to announce that UnoMeter [TM] Safeti [TM] Plus is now accepted by NHS to be included on the national listing for England. Also Observe Medical has received first order of UnoMeter [TM] Safeti [TM] Plus from Portugal and the journey to create a strategic partnership with Jiangsu Hongxin Medical Technology Co., Ltd is taking a step forward with the completion of the KYC process.


The NHS listing will make UnoMeter [TM] Safeti [TM] Plus easily available to all public hospitals across England which represents a significant opportunity, with now both UnoMeter [TM] Safeti [TM] Plus and UnoMeter [TM] 500 now represented on this listing. Also Observe Medical has received first order from Portugal which means that all products from the Convatec portfolio is now represented in Portugal.


The Company further announces the completion of the KYC process for Jiangsu Hongxin Medical Technology Co., Ltd ("JHMT"), which is the Company's largest industrial partner within manufacturing and supply paving the way for the implementation of earlier signed subscription form.


Jørgen Mann, CEO of Observe Medical, commented: "With the first order from Portugal and orders received from also France and Chile within the last 3 weeks, we have now received orders from 25 countries with a value above 10 mill NOK. These countries represent 85% or aprox. NOK 300 million of the historic Convatec sales to market, in today's currency and market pricing and this happens only 4 months after we started deliveries of UnoMeter [TM] Safeti [TM] Plus. The NHS listing means that the English hospitals will have easy access to deliveries of UnoMeter [TM] Safeti [TM] Plus and it is now up to us and our distributor C&P Medical to capitalise on this opportunity. We are also very happy to be able to announce that the process of creating a strategic partnership with our trusted partner Jiangsu Hongxin Medical Technology Co., Ltd is now moving forward"

Det er jo ikke en smånyhet det, ref selskapets verdi. Er vel ikke usansynlig at det kommer en kraftig kursjustering nå

Det blir spennende å se hvor villl kursen blir i dag. Basert på selskapets mcap på ca 25 mill kan nyheten i går gjøre at selskapet kan stige flere 100%

versegod for tips.

Ååå fader, hvorfor har jeg oversett denne? Posisjon inntatt :)

Tabbe!

Denne aksjen er kjempe billig nå.
Target 10 kr
Denne aksjen bør gå 600-700 % fra dagens lave nivå. LOAD UP AND HOLD

https://investornytt.no/observe-medical-kan-ga-til-120-kr-pa-fa-ar/

«Men hvorfor investere i Observe Medcal nå? Og hvorfor er timingen perfekt?» skrev Teigland.

Kurs den gang: 6,20
Kurs nå: 1,60

Bare å gratulere.

Skal laste med begge hendene fredag morgen
.

Gratis penger på gaten nu.
Ingen i TOP50 selger en eneste aksje
Oversikt for OBSRV (OBSERVE MEDICAL ). Oppdatert VPS 2.05.2025

01 NAVAMEDIC ASA 15.62% 4 811.7k 3 007k
02 R INVESTMENT COMPANY AS 10.92% 3 365.7k 2 104k
03 JPB AS 6.08% 1 873.6k 1 171k
04 ELI AS 4.59% 1 414.8k 884.2k
05 SKØYEN INVEST AS 3.49% 1 074.6k 671.6k
06 GINNY INVEST AS 3.20% 986.67k 616.7k
07 F2 FUNDS AS 3.12% 960k 600k
08 BJØRNTVEDT VEGARD 2.59% 797.39k 498.4k
09 RO LARS 2.44% 750.34k 469k
10 CAM AS 2.30% 707.54k 442.2k
11 SILVERCOIN INDUSTRIES AS 2.20% 679.19k 424.5k
12 PHILIP HOLDING AS 1.90% 586.67k 366.7k
13 KING KONG INVEST AS 1.73% 533.33k 333.3k
14 QUICK ISLAND INVEST AS 1.63% 502.97k 314.4k
15 JOHANSSON ERIC 1.57% 484.13k 302.6k
16 WANGESTAD ANDREAS 1.42% 437.87k 273.7k
17 LIVERMORE INVEST AS 1.40% 430.75k 269.2k
18 GUNERIUS PETTERSEN AS 1.29% 397.33k 248.3k
19 LAPAS AS 1.20% 369.95k 231.2k
20 KRISTIANSEN DAGFINN HELGE 1.09% 336k 210k
21 EM KAPITAL AS 1.04% 320.12k 200.1k
22 NORDNET BANK AB 0.92% 282.73k 176.7k
23 ABC INVEST AS 0.87% 266.67k 166.7k
24 TAJ HOLDING AS 0.86% 264.69k 165.4k
25 BJØRNTVEDT HARALD 0.69% 213.44k 133.4k
26 PETTER MØRCK HOLDING AS 0.69% 213.33k 133.3k
27 NYGAARD ARVID HALVOR 0.68% 208.02k 130k
28 MØRCK PETTER 0.66% 202.64k 126.7k
29 METAL MONKEY AS 0.64% 196.36k 122.7k
30 HAMARA INVEST AS 0.61% 186.56k 116.6k
31 UBS SWITZERLAND AG 0.59% 183.21k 114.5k
32 JTT AS 0.58% 179.07k 111.9k
33 US HOLDING AS 0.58% 177.33k 110.8k
34 LUCELLUM AS 0.57% 176k 110k
35 WIGDEL BENGT 0.49% 152.42k 95 265
36 LAGOPUS AS 0.48% 147.38k 92 114
37 KIKINN INVEST AS 0.43% 133.33k 83 333
38 DANSKE BANK A/S 0.43% 131.93k 82 455
39 BRØDRENE KARLSEN HOLDING AS 0.43% 131.19k 81 991
40 NORDNET LIVSFORSIKRING AS 0.38% 117.52k 73 448
41 SÆSTAD JAN OVE 0.37% 114.63k 71 643 1
42 OKAN KNUT IVAR 0.37% 112.57k 70 358
43 TAMULYNAS MANTAS 0.36% 109.91k 68 696
44 LYR INVEST AS 0.35% 108.48k 67 801
45 ENDRERUD ESKILD 0.35% 108k 67 500
46 ABAGUST AS 0.35% 106.67k 66 666
47 KVARTEN 1 AS 0.35% 106.67k 66 666
48 AVANZA BANK AB MEGLERKONTO 0.33% 102.93k 64 334 -3 545
49 BØLGEN HOLDING AS 0.33% 100.85k 63 033
50 TØNNESSEN LINE 0.32% 99 486 62 179
51 Other investors 14.11% 4 347.14k 2 716.68k 38 979

De er så dårlig med å tjene penger at de inngikk avtale med kreditorene. Det er ikke lett å tjene penger på urinposer ellers Convatec hadde ikke gitt bort sine urinposer på billig pris. Onserve har også en elendig historie. Undersøk et selskap grundig før dere kjøper. Har selskapet meldt når emisjonen blir?

Jeg antar at folk har lest børsmeldingen fra 10 apr:

Observe Medical has entered into agreements in principle with major creditors for a 50% debt reduction
Such debt reduction is conditional upon injection of new equity in the minimum amount of NOK 25 million..
.
.
The agreements in principle with Convatec and Navamedic will partially cover the requirement from such investors. Similar negotiations with smaller unsecured creditors will also be initiated.
.
.

This one should quickly go above 4 kr now. Buy and Hold

TARGET 10 KR. LOAD UP AND HOLD

The company said it will also have the opportunity to receive milestone payments of up to NOK 20 million based on whether Observe Medical achieves certain sales levels of Sippi.
Oslo (Infront TDN Direkt): Observe Medical announces that UnoMeter Safeti Plus has now been approved by the NHS for inclusion on the national list for England, according to a statement on Monday.

In addition, Observe Medical has received the first order for UnoMeter Safeti Plus from Portugal, and the work to establish a strategic partnership with Jiangsu Hongxin Medical Technology Co., Ltd is taking a step further with the completion of the KYC process, it said.

-- With the first order from Portugal, as well as orders from both France and Chile in the last three weeks, we have now received orders from 25 countries with a total value of over ten million NOK, says the CEO of Observe Medical in a comment.

With locked FLOAT, this stock is a nuclear bomb

Buy 50-100k shares now and get richer soon.

free float is empty now.

Oslo, April 28, 2025 - Observe Medical ("the Company" or "Observe Medical") is happy to announce that UnoMeter^TM^ Safeti^TM^ Plus is now accepted by NHS to be included on the national listing for England. Also Observe Medical has received first order of UnoMeter^TM^ Safeti^TM^ Plus from Portugal and the journey to create a strategic partnership with Jiangsu Hongxin Medical Technology Co., Ltd is taking a step forward with the completion of the KYC process.

The NHS listing will make UnoMeter^TM^ Safeti^TM^ Plus easily available to all public hospitals across England which represents a significant opportunity, with now both UnoMeter^TM^ Safeti^TM^ Plus and UnoMeter^TM^ 500 now represented on this listing. Also Observe Medical has received first order from Portugal which means that all products from the Convatec portfolio is now represented in Portugal.

The Company further announces the completion of the KYC process for Jiangsu Hongxin Medical Technology Co., Ltd ("JHMT"), which is the Company's largest industrial partner within manufacturing and supply paving the way for the implementation of earlier signed subscription form.

Jørgen Mann, CEO of Observe Medical, commented: "With the first order from Portugal and orders received from also France and Chile within the last 3 weeks, we have now received orders from 25 countries with a value above 10 mill NOK. These countries represent 85% or aprox. NOK 300 million of the historic Convatec sales to market, in today's currency and market pricing and this happens only 4 months after we started deliveries of UnoMeter^TM^ Safeti^TM^ Plus. The NHS listing means that the English hospitals will have easy access to deliveries of UnoMeter^TM^ Safeti^TM^ Plus and it is now up to us and our distributor C&P Medical to capitalise on this opportunity. We are also very happy to be able to announce that the process of creating a strategic partnership with our trusted partner Jiangsu Hongxin Medical Technology Co., Ltd is now moving forward"

MONSTER EXPLOSION COMING SOON. NOW THERE IS FREE MONEY ON THE STREET. PICK THEM UP.

De må hente minst 25 mil for å kunne overleve.
Det er 19,258,412 aksjer : 25,000,000/19,258,412= 1.298
For hver aksje eier man må man betale 1.298 kroner per aksje for å forsvare sin posisjon
Men det blir en rettet emisjon:
"Det anses foreløpig som sannsynlig at en egenkapitalinnhenting (hvis igangsatt) vil ta i form av en rettet emisjon og en påfølgende reparasjonsemisjon, opplyser selskapet."

Ofte utvannes aksjekurser med rettet emisjoner, børs-gribber prioriteres framfor småaksjonærer.
Hvis man tror på dette selskapet på liv og dø og tror at selskapet skal tjene store summer på salg av urinposer kan kjøpe etter emisjonen.